Libra Infusions (DHA:LIBRAINFU) Buyback Yield %: 0.00 (As of Jul. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:LIBRAINFU Libra Infusions Ltd DHA:LIBRAINFU
21 GF Score
Price BDT661.40
View Full Analysis

What is Libra Infusions Buyback Yield %?

Libra Infusions DHA:LIBRAINFU 21 Buyback Yield % is 0.00 as of Jul. 17, 2026. GuruFocus rates DHA:LIBRAINFU with a GF Score™ of 21/100. Among 347 Medical Devices & Instruments companies, Libra Infusions ranks worse than 288184.15% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Libra Infusions's current buyback yield was 0.00%.

Libra Infusions Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Libra Infusions's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Libra Infusions Buyback Yield % Chart

Libra Infusions Annual Data
Trend
Buyback Yield %

Libra Infusions Semi-Annual Data
Buyback Yield %

DHA:LIBRAINFU vs SECI, LENSF, ASNB: Buyback Yield % Comparison

For the Medical Instruments & Supplies subindustry, Libra Infusions's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Libra Infusions Buyback Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Libra Infusions's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Libra Infusions's Buyback Yield % falls into.


DHA:LIBRAINFU
21GF Score
Libra Infusions Ltd DHA:LIBRAINFU
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Libra Infusions Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Libra Infusions's Buyback Yield for the fiscal year that ended in . 20 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- ( + ) /
=N/A%

Libra Infusions's annualized Buyback Yield for the quarter that ended in . 20 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- ( + ) /
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of 0.00 mean?
Libra Infusions (DHA:LIBRAINFU) has a Buyback Yield % of 0.00 as of Jul. 17, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Libra Infusions and its competitors. According to the industry distribution chart, Libra Infusions ranks #999999 out of 347 companies in the Medical Devices & Instruments industry.
Is Libra Infusions' Buyback Yield % too high?
Libra Infusions' current Buyback Yield % is 0.00. Based on the distribution chart, Libra Infusions ranks #999999 out of 347 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Libra Infusions has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Libra Infusions' Buyback Yield % compare to SECI and LENSF?
According to the Medical Devices & Instruments industry distribution chart, Libra Infusions ranks #999999 out of 347 companies for Buyback Yield %. This places Libra Infusions in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Libra Infusions and its competitors. Libra Infusions's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Libra Infusions stock overvalued right now?
Libra Infusions (DHA:LIBRAINFU) has a current Buyback Yield % of 0.00. The current Buyback Yield % is 0.00. Libra Infusions' overall GF Score™ is 21/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Libra Infusions (DHA:LIBRAINFU), the current Buyback Yield % is 0.00 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Libra Infusions Business Description

Address I/7, Mirpur Industrial Estate, Rupnagar, Section-2, Dhaka, BGD, 1216
Libra Infusions Ltd is engaged in manufacturing intravenous fluids. It provides products which are used for medical purposes involving surgical operations, loss of blood, weakness, and general hospitalization.
21GF Score

Get the complete analysis for DHA:LIBRAINFU

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT661.40
Price